Sung-Geun Choi

Sung-Geun Choi

Auto-generated profile, based on publicly available information

Sung-Geun Choi

Department of Materials Science and Engineering, Seoul National University, Seoul 08826, Republic of Korea

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
JKJahyun Koo
Jahyun Koo
SKSung Bong Kim
Sung Bong Kim
YCYeon Sik Choi
Yeon Sik Choi
Zhaoqian XieZhaoqian Xie
Zhaoqian Xie
Amay BandodkarAmay Bandodkar
Amay Bandodkar
JRJohn A. Rogers
John A. Rogers
Bioresorbable drug release platforms offer advanced treatment for hormone imbalances, malignant cancers, and diabetic conditions.

5 March 2026 in Nature Sustainability
Verified
Journal Article
Closed access
PDF file
KKKyung-Sub Kim
Kyung-Sub Kim
JSJun-Seok Shim
Jun-Seok Shim
SKSung-Woo Kim
Sung-Woo Kim
GHGyeong-Seok Hwang
Gyeong-Seok Hwang
YPYou-Jung Park
You-Jung Park
Seung-Kyun KangSeung-Kyun Kang
Seung-Kyun Kang

11 July 2025 in Science Advances
Verified
Journal Article
Open access
SCSung-Geun Choi
Sung-Geun Choi
SKSeongchan Kim
Seongchan Kim
JKJoon-Woo Kim
Joon-Woo Kim
MCMyung-Kyun Choi
Myung-Kyun Choi
JHJieun Han
Jieun Han
Seung-Kyun KangSeung-Kyun Kang
Seung-Kyun Kang
Drug localization, release control, and penetration into solid tissues through biological tight junctions are crucial for the treatment of localized diseases with biological barriers by maximizing therapeutic efficacy of the drug and minimizing damage to normal organs. Here, we introduce a dual-phoretic wireless drug delivery system that harnesses the physical control of ion transportation: electrophoresis for controllable release and iontophoresis for directional penetration. Adjustable, pulsatile, and repeatable drug release under biological conditions is achieved using ion diodes and Zn-based electrochemical cells. Through seamless integration with iontophoretic compartments, a fourfold improvement in delivery efficiency compared to drug diffusion, reaching the core of in vivo tumor, is verified by a 3D tomographic analysis. Fully implantable and wireless operation in a simulated 2-week therapeutic scenario results in a remarkable 50% tumor reduction from the initial volume while minimizing damage to nearby normal tissue and off-target organs such as the heart, liver, spleen, and kidney.